• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

google plus one (home page)

Article

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Atogepant Improves QoL, Function in Adults with Chronic, Episodic, Treatment-Resistant Migraine / image credit Christopher Gottschalk, MD courtesy of Yale Medicine

Atogepant Improves QoL, Function in Adults with Chronic, Episodic, Treatment-Resistant Migraine

Grace Halsey
December 10th 2024
Article

An analysis of patient reported outcome measures from 3 pivotal phase 3 RCTs of atogepant 60 mg demonstrates efficacy across functional domains as well as for migraine prevention.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

FDA Accepts GSK’s Submission for Use of Mepolizumab in COPD

FDA Accepts GSK’s Submission for Use of Mepolizumab in COPD

Sydney Jennings
December 9th 2024
Article

The Prescription Drug User Fee Act date is set for May 7, 2025.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Sydney Jennings
October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Influenza Antiviral Treatment Underutilized Among Vulnerable Youth: Daily Dose / image credit: ©New Africa/AdobeStock

Influenza Antiviral Treatment Underutilized Among Vulnerable Youth: Daily Dose

Sydney Jennings
December 6th 2024
Article

Your daily dose of the clinical news you may have missed.

Dupilumab Effective in Young Children with Atopic Dermatitis, Comorbid T2 Inflammatory Disease

Dupilumab Effective in Young Children with Atopic Dermatitis, Comorbid T2 Inflammatory Disease

Grace Halsey
December 5th 2024
Article

Dupilumab significantly reduced signs and symptoms of AD in children aged 6 months to 5 years with concomitant asthma, allergic rhinitis, and food allergy.

© 2024 MJH Life Sciences

All rights reserved.